Literature DB >> 26886840

FLT3 Inhibitor-Associated Neutrophilic Dermatoses.

Nisha Varadarajan1, Andrea Boni2, David E Elder3, Adam Bagg3, Robert Micheletti4, Alexander E Perl5, Misha Rosenbach4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26886840     DOI： 10.1001/jamadermatol.2015.6121

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  9 in total

1.  Gilteritinib induces differentiation in relapsed and refractory FLT3-mutated acute myeloid leukemia.

Authors:  Christine M McMahon; Jonathan Canaani; Bryan Rea; Rachel L Sargent; Julianne N Qualtieri; Christopher D Watt; Jennifer J D Morrissette; Martin Carroll; Alexander E Perl
Journal:  Blood Adv       Date:  2019-05-28

Review 2.  The role of targeted therapy in the management of patients with AML.

Authors:  Alexander E Perl
Journal:  Blood Adv       Date:  2017-11-14

Review 3.  The role of targeted therapy in the management of patients with AML.

Authors:  Alexander E Perl
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

4.  FDA Approval Summary: Gilteritinib for Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation.

Authors:  E Dianne Pulte; Kelly J Norsworthy; Yaping Wang; Qing Xu; Hisham Qosa; Ramadevi Gudi; Donna Przepiorka; Wentao Fu; Olanrewaju O Okusanya; Kirsten B Goldberg; R Angelo De Claro; Ann T Farrell; Richard Pazdur
Journal:  Clin Cancer Res       Date:  2021-02-25       Impact factor: 13.801

Review 5.  Insights Into the Pathogenesis of Sweet's Syndrome.

Authors:  Michael S Heath; Alex G Ortega-Loayza
Journal:  Front Immunol       Date:  2019-03-12       Impact factor: 7.561

Review 6.  Recent drug approvals for acute myeloid leukemia.

Authors:  Catherine Lai; Kimberley Doucette; Kelly Norsworthy
Journal:  J Hematol Oncol       Date:  2019-09-18       Impact factor: 17.388

Review 7.  Neutrophilic Dermatoses: a Clinical Update.

Authors:  Emma H Weiss; Christine J Ko; Thomas H Leung; Robert G Micheletti; Arash Mostaghimi; Sarika M Ramachandran; Misha Rosenbach; Caroline A Nelson
Journal:  Curr Dermatol Rep       Date:  2022-03-16

8.  Sweet's syndrome in a granulocytopenic patient with acute myeloid leukemia on FLT3 inhibitor.

Authors:  Anish Paudel; Rashmi Dhital; Gabriel Areoye; Sijan Basnet; Niranjan Tachamo
Journal:  J Community Hosp Intern Med Perspect       Date:  2020-06-14

Review 9.  Differentiation therapy of myeloid leukemia: four decades of development.

Authors:  Vikas Madan; H Phillip Koeffler
Journal:  Haematologica       Date:  2021-01-01       Impact factor: 9.941
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.